Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title
Sort descending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
|
Education | Hospital | All | |
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
|
Education | Oncology | All | |
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
|
Education | Oncology | USA | |
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
|
Quality Improvement | Rare Disease | Canada | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
|
Education | Health Equity | China | |
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
|
Education | Internal Medicine | All | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA |
| Title
Sort descending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Pediatric and Adolescent Migraine
Release Date:
|
||||
Improving Chronic Pain Outcomes
Release Date:
|
||||
Chronic Pain Care- Interprofessional Team
Release Date:
|
||||
Cardiovascular Risk In Rheumatoid Arthritis
Release Date:
|
||||
Management of Flares in Rheumatoid Arthritis Patients
Release Date:
|
||||
Patient Care in Rheumatoid Arthritis
Release Date:
|
||||
Global Bridges Smoking Cessation
Release Date:
|
||||
Smoking Cessation
Release Date:
|
||||
Immunizations in Young Adolescents
Release Date:
|
||||
Adult Immunization in Low- and Middle-Income Countries
Release Date:
|
||||
Enabling Effective Conversations About Menopausal Vasomotor Symptoms
Release Date:
|
||||
Transition of Care in VTE
Release Date:
|